9-127707116-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001012502.3(CFAP157):c.85G>A(p.Val29Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,613,726 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001012502.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP157 | NM_001012502.3 | c.85G>A | p.Val29Met | missense_variant | 1/9 | ENST00000373295.7 | NP_001012520.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP157 | ENST00000373295.7 | c.85G>A | p.Val29Met | missense_variant | 1/9 | 5 | NM_001012502.3 | ENSP00000362392.1 | ||
PTRH1 | ENST00000335223.5 | c.205+8319C>T | intron_variant | 1 | ENSP00000493136.1 | |||||
CFAP157 | ENST00000614677.1 | c.85G>A | p.Val29Met | missense_variant | 1/9 | 2 | ENSP00000478313.1 | |||
CFAP157 | ENST00000496009.5 | n.128G>A | non_coding_transcript_exon_variant | 1/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248706Hom.: 1 AF XY: 0.0000370 AC XY: 5AN XY: 135092
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461458Hom.: 2 Cov.: 30 AF XY: 0.0000743 AC XY: 54AN XY: 727054
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74448
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at